Related Experiment Video
Updated: Feb 22, 2026

Longitudinal In Vivo Imaging and Quantification of Human Pancreatic Islet Grafting and Contributing Host Cells in the Anterior Eye Chamber
Published on: June 11, 2020
[Advanced diabetes technology: clinical application and practical implications]
Rowan V Toet1,2, Behiye Özcan1, Mandy van Hoek1
1Erasmus MC, afd. Interne geneeskunde, Rotterdam.
Advanced diabetes technologies like continuous glucose monitoring (CGM) and hybrid closed-loop (HCL) systems improve glycemic control and quality of life. Personalized implementation is key for optimizing outcomes in diabetes management.
Area of Science:
- Endocrinology
- Medical Technology
Background:
- Diabetes mellitus is a chronic condition significantly impacting quality of life.
- Traditional treatments include insulin injections and self-monitoring.
- Technological advancements offer new avenues for glycemic control.
Purpose of the Study:
- To review the impact of modern diabetes technologies on glycemic control and patient outcomes.
- To highlight the benefits of continuous glucose monitoring (CGM), insulin pumps, and hybrid closed-loop (HCL) systems.
- To discuss the importance of personalized implementation of these technologies.
Main Methods:
- Review of clinical evidence on diabetes management technologies.
- Analysis of outcomes including HbA1c, Time in Range (TIR), and hypoglycemia.
- Consideration of patient-specific factors for technology adoption.
Main Results:
- CGM, HCL systems, and connected devices reduce HbA1c and increase TIR.
- These technologies lower the risk of severe hypoglycemia.
- Improved quality of life and psychosocial outcomes are associated with technology use.
Conclusions:
- Diabetes technology offers significant benefits for glycemic control and well-being.
- Tailored implementation considering patient factors is crucial for success.
- Clinicians must stay informed about evolving technologies for effective diabetes care.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Diabetes Mellitus: Type 2 and Gestational

